These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 8560403)

  • 1. Thromboxane biosynthesis, neutrophil and coagulative activation in type IIa hypercholesterolemia.
    Davì G; Ganci A; Averna M; Giammarresi C; Barbagallo C; Catalano I; Calà A; Notarbartolo A
    Thromb Haemost; 1995 Oct; 74(4):1015-9. PubMed ID: 8560403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased thromboxane biosynthesis in type IIa hypercholesterolemia.
    Davì G; Averna M; Catalano I; Barbagallo C; Ganci A; Notarbartolo A; Ciabattoni G; Patrono C
    Circulation; 1992 May; 85(5):1792-8. PubMed ID: 1572035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of thromboxane biosynthesis and platelet function by simvastatin in type IIa hypercholesterolemia.
    Notarbartolo A; Davì G; Averna M; Barbagallo CM; Ganci A; Giammarresi C; La Placa FP; Patrono C
    Arterioscler Thromb Vasc Biol; 1995 Feb; 15(2):247-51. PubMed ID: 7749833
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Determinants of enhanced thromboxane biosynthesis in patients with systemic lupus erythematosus.
    Ferro D; Basili S; Roccaforte S; Di Franco M; Cipollone F; Ciabattoni G; Davì G
    Arthritis Rheum; 1999 Dec; 42(12):2689-97. PubMed ID: 10616019
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD40 ligand enhances monocyte tissue factor expression and thrombin generation via oxidative stress in patients with hypercholesterolemia.
    Sanguigni V; Ferro D; Pignatelli P; Del Ben M; Nadia T; Saliola M; Sorge R; Violi F
    J Am Coll Cardiol; 2005 Jan; 45(1):35-42. PubMed ID: 15629370
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increased thromboxane biosynthesis in essential thrombocythemia.
    Rocca B; Ciabattoni G; Tartaglione R; Cortelazzo S; Barbui T; Patrono C; Landolfi R
    Thromb Haemost; 1995 Nov; 74(5):1225-30. PubMed ID: 8607099
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term treatment with atorvastatin reduces platelet CD40 ligand and thrombin generation in hypercholesterolemic patients.
    Sanguigni V; Pignatelli P; Lenti L; Ferro D; Bellia A; Carnevale R; Tesauro M; Sorge R; Lauro R; Violi F
    Circulation; 2005 Feb; 111(4):412-9. PubMed ID: 15687128
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of diet and treatment with statins on platelet-dependent thrombin generation in hypercholesterolemic subjects.
    Puccetti L; Bruni F; Bova G; Cercignani M; Palazzuoli A; Console E; Auteri A; Pasqui AL
    Nutr Metab Cardiovasc Dis; 2001 Dec; 11(6):378-87. PubMed ID: 12055702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of two different HMG-CoA reductase inhibitors on thromboxane production in type IIA hypercholesterolemia.
    Milani M; Cimminiello C; Lorena M; Arpaia G; Soncini M; Bonfardeci G
    Biomed Pharmacother; 1996; 50(6-7):269-74. PubMed ID: 8952866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased thromboxane metabolites excretion in liver cirrhosis.
    Davì G; Ferro D; Basili S; Iuliano L; Camastra C; Giammarresi C; Santarone S; Rocca B; Landolfi R; Ciabattoni G; Cordova C; Violi F
    Thromb Haemost; 1998 Apr; 79(4):747-51. PubMed ID: 9569186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lipid-lowering effects of simvastatin and gemfibrozil in CAPD patients: a prospective cross-over study.
    Akçiçek F; Ok E; Duman S; Kürsad S; Unsal A; Alev M; Atabay G; Basçi A
    Adv Perit Dial; 1996; 12():261-5. PubMed ID: 8865916
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fluvastatin reduces soluble P-selectin and ICAM-1 levels in hypercholesterolemic patients: role of nitric oxide.
    Romano M; Mezzetti A; Marulli C; Ciabattoni G; Febo F; Di Ienno S; Roccaforte S; Vigneri S; Nubile G; Milani M; Davì G
    J Investig Med; 2000 May; 48(3):183-9. PubMed ID: 10822898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Residual effects of lovastatin and simvastatin on urinary mevalonate excretions in patients with familial hypercholesterolemia.
    Pappu AS; Bacon SP; Illingworth DR
    J Lab Clin Med; 2003 Apr; 141(4):250-6. PubMed ID: 12677170
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determinants of enhanced thromboxane biosynthesis in renal transplantation.
    Averna M; Barbagallo CM; Ganci A; Giammarresi C; Cefalù AB; Sparacino V; Caputo F; Basili S; Notarbartolo A; Davì G
    Kidney Int; 2001 Apr; 59(4):1574-9. PubMed ID: 11260423
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced thromboxane biosynthesis in patients with chronic obstructive pulmonary disease. The Chronic Obstructive Bronchitis and Haemostasis Study Group.
    Davì G; Basili S; Vieri M; Cipollone F; Santarone S; Alessandri C; Gazzaniga P; Cordova C; Violi F
    Am J Respir Crit Care Med; 1997 Dec; 156(6):1794-9. PubMed ID: 9412557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of thromboxane biosynthesis in rheumatoid arthritis: Role of RAGE and oxidant stress.
    Ferrante E; Vazzana N; Santilli F; Di Cicco M; Lauriti C; Di Battista L; Ciabattoni G; Di Matteo L; Davì G
    Free Radic Biol Med; 2010 Sep; 49(5):857-64. PubMed ID: 20541603
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiphospholipid antibodies enhance thrombin-induced platelet activation and thromboxane formation.
    Martinuzzo ME; Maclouf J; Carreras LO; Lévy-Toledano S
    Thromb Haemost; 1993 Oct; 70(4):667-71. PubMed ID: 8115993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enhanced lipid peroxidation and platelet activation in the early phase of type 1 diabetes mellitus: role of interleukin-6 and disease duration.
    Davì G; Chiarelli F; Santilli F; Pomilio M; Vigneri S; Falco A; Basili S; Ciabattoni G; Patrono C
    Circulation; 2003 Jul; 107(25):3199-203. PubMed ID: 12810609
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thromboxane-dependent CD40 ligand release in type 2 diabetes mellitus.
    Santilli F; Davì G; Consoli A; Cipollone F; Mezzetti A; Falco A; Taraborelli T; Devangelio E; Ciabattoni G; Basili S; Patrono C
    J Am Coll Cardiol; 2006 Jan; 47(2):391-7. PubMed ID: 16412866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelet activity in vivo in hyperlipoproteinemia--importance of combined hyperlipidemia.
    Bröijersén A; Hamsten A; Eriksson M; Angelin B; Hjemdahl P
    Thromb Haemost; 1998 Feb; 79(2):268-75. PubMed ID: 9493574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.